Er-Kim Ilac Sanayi ve Ticaret A.S. Celebrates Its 35th Anniversary

ErKimBasinBulteni-1601 20160307

Active Substance



Er-Kim Ilac has been founded in 1981 and began its operations in Turkey as being the 1st company who imported the oncology products. This year, it celebrates its 35th anniversary.

Er-Kim Ilac, known as the “Company of Firsts”, has imported and introduced many specialty products for physicians’ usage in order to fulfill the “unmet needs” in Turkey and has taken a leading part in the treatment of important diseases during the 35 years it has existed in the Turkish pharmaceutical industry.

Over the years, Er-Kim Ilac has presented to the Turkish market life-saving original/patented products of many international companies that bring great value to patients’ lives and has distinguished itself with a consistent record of success. These successes led the way for the main companies to establish their own organizations in Turkey and grow even further. Er-Kim Ilac has been the exclusive distributor of 7 companies which have activities with their names in Turkey market today and are AIFD member.

As of today, Er-Kim Ilac continues to be the exclusive distributor of the drugs, medicinal devices and over-the-counter products of 11 international companies and has introduced its domestically manufactured products into the Turkish market.

“Introducing new and cost-effective treatment alternatives to Turkey” being its key mission, Er-Kim Ilac plans and executes all its activities based on this quest. Er-Kim Ilac puts on great effort to introduce the unavailable treatment alternatives in Turkey into the service of healthcare professionals and thereby patients, and also contributes to public healthcare savings by adding the affordable equivalents of the products to its portfolio within the scope of domestic contracted manufacturing agreements.

Er-Kim Ilac has achieved remarkable successes and presented many new concepts with the innovative products that it has introduced especially in the fields of Hematology and Oncology. Currently, with its diversified portfolio, it covers a wide range of different therapeutic areas such as Immunology, Neurology, Urology, Gynecology & Obstetrics, Orthopedics, Physiotherapy, Gastroenterology, Infectious Diseases, Transplantation, Dermatology, Endocrinology, Ophthalmology and Intensive Care.

Er-Kim Ilac continues to present imported Rx-only pharmaceutical products into the service of Turkish Medicine while also endeavoring to look after added values for patients/physicians and extends its portfolio with generics, medical devices, food supplements and over-the counter products.

Er-Kim Ilac has decided to enlarge its business in nearby countries through using the knowledge, experience and human resources it has gained until now and has already taken the first steps on this aim.

Er-Kim Ilac strives to meet the needs of the medicine and pharmaceutical industries and continues to take firm steps forward to bring added value to human life.